Endometrial intraepithelial neoplasia (also known as 'EIN') is a precursor to endometrioid endometrial adenocarcinoma characterized by monoclonal growth of mutated cells, a distinctive histopathologic appearance, and 45-fold elevated cancer risk. We have applied diagnostic criteria for EIN to 97 successive endometrial biopsies classified as hyperplastic according to World Health Organization criteria and correlated results with computer-assisted morphometry (D-score) and clinical cancer outcomes. Three pathologists separately reviewed all cases for presence or absence of EIN using published criteria (gland area4stromal area, cytologic change in focus of altered architecture, lesion size 41 mm, and exclusion of cancer and mimics). Discordant cases were resolved by a consensus review at a multiheaded scope. Clinical outcomes were obtained in 84 patients from patient visit and pathology records. Diagnoses of presence or absence of EIN were unanimous among all three pathologists in 75% of cases, and intraobserver-reproducibility was very good (kappa 0.73-0.90). Cases rediagnosed as EIN encompassed hyperplasias previously diagnosed as atypical (n ¼ 18) or nonatypical (eight complex, two simple). Eight follow-up cancers were scattered between hyperplasia types (5/21 atypical, 3/63 nonatypical), but all classified as EIN (8/25) and D-score r1 (8/38). Subjective application of criteria for diagnosis of EIN correlates well with objective morphometry and successfully segregates patients into high and low cancer risk subgroups with better reproducibility than atypical hyperplasia diagnosis. Keywords: EIN; endometrial hyperplasia; histomorphometry; precancer; pathology; prognosis Diagnosis and therapeutic ablation of premalignant lesions of the endometrium is central to endometrial cancer prevention. Accurate diagnosis of precursors to endometrioid endometrial cancer (Type I), 1,2 which may precede cancer by several years, presents a major challenge to pathologists. The World Health Organization (WHO) endometrial hyperplasia schema captures many precancers in the atypical hyperplasia subgroup, but is a poorly reproducible system. This report examines clinical performance of the alternative EIN diagnostic schema as practiced subjectively at our institution (BWH) since 2002.The endometrial intraepithelial neoplasia (EIN) diagnostic schema 3,4 is the end product of combined molecular, 5,6 objective histomorphometric, 7 and clinical outcome studies 8-11 specifically intended to redefine the histopathologic appearance of highrisk endometrial lesions. Premalignant lesions arise as clonal outgrowths of somatically mutated cells that present histologically as an expanding discrete focus of crowded glands with a distinctly different cytology than the background endometrium. The EIN schema more precisely defines 'atypia' and gland crowding than previous criteria for hyperplasia. The absolute cytology of EIN lesions varies greatly between patients, and in a number of cases lacks prominent nucleoli or nuclear rounding, definitions of '...